Increasing incidence of thyroid cancer has been observed in some countries such as the United States, United Kingdom, France, and so on. Joinpoint regression was used to analyze the incidence of thyroid cancer in Shanghai, China, from 1983 to 2007. The results showed that there were 2 distinct slopes: in men, representing a significant annual percentage change (APC) of 2.6% from 1983 to 2000 (P < .001) followed by a sharp APC of 14.4% (P < .001), and in women, representing a significant APC of 4.9% from 1983 to 2003 (P < .001) followed by a sharp APC of 19.9% (P = .001). The sharp increase in thyroid cancer occurred 5 and 8 years after the iodine supplementation by salt, for men and women, respectively, suggesting that either the developed screening techniques or iodine supplementation might have contributed to the rapid increase in the incidence of thyroid cancer. The burden of thyroid cancer cases is expected to be substantial, based on predictions through 2020.
KolonelLNHankinJHWilkensLRFukunagaFHHindsMW. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control. 1990;1:223-234.
2.
FerlayJAutierPBoniolMHeanueMColombetMBoyleP. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581-592.
3.
PaksoyNMontavilleBMcCarthySW. Cancer occurrence in Vanuatu in the South Pacific, 1980-86. Asia Pac J Public Health. 1989;3:231-236.
4.
ParkinDMMuirCS. Cancer incidence in five continents: comparability and quality of data. IARC Sci Publ. 1992;120:45-173.
5.
DaviesLWelchHG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
6.
Office for National Statistics, Cancer Statistics Registrations. Registrations of cancer diagnosed in 2007, England. London, UK: National Statistics; 2010. Series MB1 no. 38.
7.
ColonnaMGrosclaudePRemontetL. Incidence of thyroid cancer in adults recorded by French cancer registries. Eur J Cancer. 2002;38:1762-1768.
8.
LiuSSemenciwRUgnatAMMaoY. Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer. 2001;85:1335-1339.
9.
BurgessJR. Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid. 2002;12:141-149.
10.
KoikeANaruseT. Incidence of thyroid cancer in Japan. Semin Surg Oncol. 1991;7:107-111.
11.
FarahatiJGelingMMäderU. Changing trends of incidence and prognosis of thyroid carcinoma in Lower Franconia, Germany, from 1981-1995. Thyroid. 2004;14:141-147.
12.
Dal MasoLLiseMZambonP. Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects. Ann Oncol. 2011;22:952-963.
13.
Rego-IraetaAPérez-MéndezLFMantinanBGarcia-MayorRV. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid. 2009;19:333-340.
14.
Shanghai Municipal Center for Disease Control and Prevention & Shanghai Cancer Institute. The incidence of malignant tumor in urban Shanghai, 1983-2007. Tumor. 2010;30:595.
15.
ParkinDMWhelanSLFerlayJStormH. Cancer Incidence in Five Continents. Vols 1-8. Lyon, France: IARC CancerBase No. 7; 2005.
16.
KimHJFayMPFeuerEJMidthuneDN. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-351.
17.
BurgessJRTuckerP. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroidology. 2006;16:47-53.
18.
MorrisLGMyssiorekD. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010;200:454-461.
19.
MorrisLGSikoraAGMyssiorekDDeLacureMD. The basis of racial differences in the incidence of thyroid cancer. Ann Surg Oncol. 2008;15:1169-1176.
20.
LeeLPatrickW. A Statement on the importance of nutrition in public health by the Asia Pacific Academic Consortium of Schools of Public Health Meeting in Shanghai, Peoples’ Republic of China, October 20-23, 2003. Asia Pac J Public Health. 2004;16:72.
21.
DelangeF. Risks and benefits of iodine supplementation. Lancet. 1998;351:923-924.
22.
SoveidMMonabbatiASooratchiLDahtiS. The effect of iodine prophylaxis on the frequency of thyroiditis and thyroid tumors in Southwest, Iran. Saudi Med J. 2007;28:1034-1038.
23.
HarachHREscalanteDADayES. Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis. Endocr Pathol. 2002;13:175-181.
24.
HarachHRCeballosGA. Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model. Endocr Pathol. 2008;19:209-220.
25.
HarachHRWilliamsED. Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Clin Endocrinol. 1995;43:701-706.
26.
HofstadterF. Frequency and morphology of malignant tumours of the thyroid before and after the introduction of iodine-prophylaxis. Virchows Arch. 1980;385:263-270.
27.
Venkatesh MannarMG. Salt Iodization Around the World: Achievements and Challenges: Proceedings of the 8th World Salt Symposium, Hague, Netherlands. Amsterdam, the Netherlands: Elsevier; 2000.
